CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 21 November 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00362-07v1
15/2/194    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hao, W.
Right arrow Articles by Che, X.-y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hao, W.
Right arrow Articles by Che, X.-y.
Clin. Vaccine Immunol. doi:10.1128/CVI.00362-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Well-Characterized Monoclonal Antibodies Against Cell Wall Antigen of Aspergillus Species Improve Immunoassay Specificity and Sensitivity

Wei Hao, Yu-xian Pan, Yan-qing Ding, Sha Xiao, Kai Yin, Ya-di Wang, Li-wen Qiu, Qing-lin Zhang, Patrick C. Y. Woo, Susanna K. P. Lau, Kwok-yung Yuen, and Xiao-yan Che*

Center of Laboratory, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Department of Pathology, School of Basic Medical Science, Southern Medical University Guangzhou, China; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Department of Microbiology, The University of Hong Kong, Hong Kong Special Administrative Region, China

* To whom correspondence should be addressed. Email: linche{at}pub.guangzhou.gd.cn.


   Abstract

The diagnosis of invasive aspergillosis (IA) based on the detection of Aspergillus galactomannan (GM) is complicated by the presence of cross-reactive GM epitopes in patient specimens. Presently, we have developed a novel and specific Aspergillus antigen capture enzyme-linked immunosorbent assay (ELISA) by selection of two well-characterized monoclonal antibodies from 17 candidate antibodies. The epitopes recognized by the monoclonal antibodies were present on the cell wall of hyphae and conidia of Aspergillus species, which were circulating or excreted as immunodominant antigens during the acute phase of IA established in the animal models. Detection of experimental Aspergillus-mediated antigenemia was suitably sensitive and was comparable to a commercial GM detection ELISA kit (Platelia Aspergillus). Moreover, the specificity of this assay was 100% when tested against 382 normal serum and 120 normal urine specimens. Cross-reactivity with other common opportunistic fungi such as Penicillium and Candida species, and with purified GM protein derived from Aspergillus, was not evident. Therefore, this chemical nature of epitopes captured in this assay is most likely not associated with the GM structure, implicating this newly developed Aspergillus antigen capture ELISA assay as a promising tool for the diagnosis of IA without the risk of false-positive results that are problematic in current GM antigen assays.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.